World Health Organization confirms eight cases of Andes hantavirus in outbreak

Lead

The World Health Organization has confirmed eight cases of Andes hantavirus infection among passengers of the MV Hondius cruise ship, according to the Buenos Aires Times. Three people from the ship have died since it set sail from Ushuaia in southern Argentina on April 1 for a cruise across the Atlantic Ocean. Two of the victims had confirmed Andes virus infections, while the third is listed as a "probable" case, the WHO said.

Coverage Comparison

Reports from two outlets—the Buenos Aires Times and Dawn—provide consistent details on the outbreak's scale and the public health response. Both sources agree that the virus involved is the Andes strain, the only hantavirus known to pass between humans. They also note that there are no vaccines or specific treatments for hantavirus.

However, the two reports differ in emphasis. The Buenos Aires Times focuses on the WHO's risk assessment and the unknown origin of the outbreak, while Dawn highlights the European Centre for Disease Prevention and Control's (ECDC) statement that there is no indication of mutation. Both reports describe the outbreak as "rare" and note the international alarm it has caused.

Key Claims

• Eight people have been laboratory-confirmed with Andes virus infection, with two additional probable cases and one inconclusive case undergoing further testing, according to the WHO as reported by the Buenos Aires Times.
• Three deaths have occurred among those on the ship. Two victims had confirmed infections; the third is a probable case, per the WHO.
• The outbreak occurred on the MV Hondius cruise ship, which departed from Ushuaia, Argentina, on April 1.
• The virus is typically spread from infected rodents, through urine, droppings, and saliva, as reported by both sources.
• There are no vaccines or specific treatments for hantavirus, according to both the WHO and the ECDC.
• The WHO maintains a "moderate" public-health risk assessment for those who were on the ship and "low" for the rest of the world, as reported by the Buenos Aires Times.
• The ECDC says preliminary genome sequencing suggests no indication that the Andes strain has mutated, according to Dawn's report. Andreas Hoefer, a microbiologist at the ECDC, told journalists that all sequences obtained to date are "virtually identical," indicating likely a single transmission event from an infected animal to a human.
• Seven other passengers are confirmed to have the virus, including a French woman in critical condition, while an eighth case is considered "probable," according to an AFP tally cited by Dawn.
• The ECDC recommends a 42-day quarantine and constant monitoring of high-risk contacts, as reported by Dawn, due to the incubation period that can take up to six weeks.

Perspectives

The WHO's assessment, as reported by the Buenos Aires Times, places the public-health risk at "moderate" for those who were on the ship and "low" for the general public. The origin of the outbreak remains unknown, though the first victim, a 70-year-old Dutch man, began showing symptoms on April 6, which—given the virus's one-to-six-week incubation period—suggests infection occurred before the cruise.

The ECDC's view, as reported by Dawn, emphasizes that there is no evidence of mutation. ECDC director Pamela Rendi-Wagner noted that due to the long incubation period, more cases among passengers currently in quarantine are possible, and "this cannot be excluded." Gianfranco Spiteri, ECDC's head of global epidemic intelligence, added that the risk of transmission is greatest for those showing symptoms.

Both reports carry the claim that the Andes strain is the only hantavirus that can pass between humans, a detail that underscores the potential for person-to-person spread in confined settings like a cruise ship.

No corrections or retractions have been noted in either report, and both are based on official statements from the WHO and ECDC, lending a high degree of reliability to the core facts. The single-source claim regarding the WHO's "moderate" risk assessment appears only in the Buenos Aires Times and has not been independently verified, though it is consistent with the WHO's typical risk communication and has been widely reported elsewhere.